UPDATE 1-AtriCure's heart device gets FDA approval; shares up
* To launch device later this month
* Shares up 17 pct after market
June 14 (Reuters) - AtriCure Inc (ATRC.O) said U.S. health regulators approved its device that helps prevent blood clots in the heart, sending its shares up 17 percent.
The company said its AtriClip system prevents blood from entering and forming clots in the left atrial appendage, a hollow sac-like structure attached to the heart's left upper chamber, during irregular heart beats.
AtriCure plans to launch the device later this month in the United States.
Shares of the company were up 90 cents at $6.13 in after-market trade. They closed at $5.23 Monday on Nasdaq. (Reporting by Anand Basu in Bangalore; Editing by Vinu Pilakkott)
- Malaysia Airlines plane missing, presumed crashed in South China Sea |
- CORRECTED-UPDATE 4-Malaysia Airlines plane crashes in South China Sea with 239 people aboard - report
- China draws 'red line' on North Korea, says won't allow war on peninsula
- Malaysian plane crashed off Vietnam coast: state media
- No signal picked up from missing Malaysia Airlines plane-Vietnam official